We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | 1.10 | 1.40 | 1.25 | 1.25 | 1.25 | 296,158 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.57 | 1.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/12/2020 20:20 | Space, who knows, though not sure how it can be commercialized, as when pyc do a dose prediction setup for a drug and give it to the client, it's now their data, as they have paid for it. If they want to use it in an app thats pretty much up to them. | davevt | |
17/12/2020 19:45 | Are we guilty of some of this. I am a little even though it was hard to admit. Watch this short clip. BE WARNED YOU'LL NEED A HANKY OR 2 | spacedust | |
17/12/2020 19:43 | Regardless this will be 15p plus tomorrow. | spacedust | |
17/12/2020 19:43 | Hiw much could a commercialisation deal be worth? | spacedust | |
17/12/2020 19:12 | Incredible potential to utilise Big Data/AI/ML to improve scheduling, sequencing, combinations, dosing of cancer treatment regimens in this $200 Billion p.a. market ! Physiomics have spent 20 years building up their Virtual Tumour Model to understand from the ground up how cancer therapeutics work and crucially how they work in combinations The UK Government/NHS/NIHR funding and trials have been crucial validation AS WELL as giving us crucial access to data in the NHS data 'goldmine' Now with support of a BIG US Partner we have the potential to commercialise our modelling algorithms in the biggest Healthcare market in the World That is why you get $5bn start-ups in the field of Cancer AI or Personalised Oncology such as Tempus Labs... | the stigologist | |
17/12/2020 18:36 | These boards are for people to discuss investing in a share, not to be caught out correct? To buy in at the best price and get out before a fall yes? Well isn't that exactly what I discuss? The problem with boards like this, is they are full of people who are already invested, who have no interest in above as it's contrary to their goals...and ironically they also screw up any gains. Boards like this should be the moment you are invested, you shouldn't be allowed to post....because think about it, what have they got to discuss which isn't going to be totally biased, one sided, and exaggerated. | davevt | |
17/12/2020 18:31 | davevt, curious, are you invested in PYC? This is indeed great news today and yet not everyone seems happy. Just trying to understand whether you're just here to share some historical frustration or whether you have any real interest in PYC? I am all up for different opinions, makes for healthier discussions. | rolaw1 | |
17/12/2020 18:22 | Why did it fall back from 30 p ? | arab3 | |
17/12/2020 18:11 | PYC has a history of 100p+ superspikes... #justsaying And it's put in one hell of a solid base since the last ones ! | the stigologist | |
17/12/2020 18:03 | Lovely candle AND breakout of 50 day and 200 day Moving Averages on volume Expect to take out 52 week Closing high tomorrow if not the 17p intraday 52 week high as well The fundamentals certainly justify that | the stigologist | |
17/12/2020 17:58 | 12p tomorrow on the way .Dyor | tmmalik | |
17/12/2020 17:57 | Such low shares in issue make this move and fast. | markth126 | |
17/12/2020 17:55 | How far can the re rating goes when the implications sink in & still only valued at around £9mill ? | base7 | |
17/12/2020 17:29 | 2 RNS's in one day. Both positive. Cant be bad. | regandharry5 | |
17/12/2020 17:29 | Rather important drug this.Don't you think so Dave?...My Mrs could have done with more optimised dose of this. It did the job thankfully. However the side effect of neutropenic sepsis is a dangerous state. | officerdigby | |
17/12/2020 17:20 | Love your optimism Dave. | bobby.ifa | |
17/12/2020 17:16 | Just desperate. At least Albert said good luck guys | markth126 | |
17/12/2020 17:10 | Staying power = trapped in at a loss I love how you throw around 100p as a valuation with no means or basis on how you get to that calculation. You might as well say 5 quid.. | davevt | |
17/12/2020 17:10 | He has staying power. He believed in the 100p Manifesto, and he will get his wish by the look of it. | hodhasharon | |
17/12/2020 17:08 | Expert Stig? 😂 yes because he really predicted this? Everyone that's listened to Stig has bought in high and sitting at a loss. Anyone that listens to me buys in low and makes a profit. Last time I checked experts make money out of shares, not be underwater longer than everyone. Remember the hype 'they are going to have their own dose prediction tool'.....well no, they may have their calculations put into someone else's. | davevt | |
17/12/2020 17:00 | Well done to all those who listened to the expert (Stig), and not those two muppets Dave and Albert. | hodhasharon | |
17/12/2020 16:57 | Who else is a company that does dosing requirements for cancer drugs going to be 'rubbing shoulders' with? | davevt | |
17/12/2020 16:54 | Shows KUDOS to be rubbing shoulders with the big boys & may help open other doors. | bobby.ifa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions